Company Profile
Public information reviewedAdagene Inc.
Adagene Inc. functions as a clinical-stage biopharmaceutical organization, primarily concentrating on the identification, evolution, and fabrication of monoclonal antibody-based therapeutics engineered to combat various types of cancer.
USNASDAQ: ADAG
Follow
More
- Evidence records
- 2
- Published leadership records
- 17
- Record reviewed
- Sep 26, 2026

